GLP-1 medications work by reducing appetite and slowing digestion, which can sometimes lead to reduced nutrient intake or lower energy levels
The Sucrosomial carrier system significantly enhances bioavailability, allowing B12 to be absorbed more efficiently, possibly bypassing the IF pathway
Therefore, it is understandable that most drugs had moderate effects at best
[DOI] [PMC free article] [PubMed] [Google Scholar] 71.Boban Blagaic A., Turcic P., Blagaic V., Dubovecak M., Jelovac N., Zemba M., Radic B., Becejac T., Rokotov D.S., Sikiric P
These factors suggest starting slightly higher than the minimum effective clinical dose to account for real-world variability